These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2384864)

  • 21. The effect of treatment with zidovudine with or without acyclovir on HIV p24 antigenaemia in patients with AIDS or AIDS-related complex.
    Pedersen C; Cooper DA; Brun-Vézinet F; Doherty R; Skinhøj P; Pérol Y; Lüthy R; Leibowitch J; Habermehl KO; Varnier OE
    AIDS; 1992 Aug; 6(8):821-5. PubMed ID: 1418778
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial.
    Richman DD; Fischl MA; Grieco MH; Gottlieb MS; Volberding PA; Laskin OL; Leedom JM; Groopman JE; Mildvan D; Hirsch MS
    N Engl J Med; 1987 Jul; 317(4):192-7. PubMed ID: 3299090
    [TBL] [Abstract][Full Text] [Related]  

  • 23. T activation marker evaluation in ARC patients treated with AZT. Comparison with CD4+ lymphocyte count in non-progressors and progressors towards AIDS.
    Levacher M; Tallet S; Dazza MC; Dournon E; Rouveix B; Pocidalo JJ
    Clin Exp Immunol; 1990 Aug; 81(2):177-82. PubMed ID: 1696859
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Failure to maintain high-dose treatment regimens during long-term use of zidovudine in patients with symptomatic human immunodeficiency virus type 1 infection.
    van Leeuwen R; van den Hurk PJ; Jöbsis GJ; van der Wouw PA; Reiss P; Eeftinck Schattenkerk JK; Danner SA; Lange JM
    Genitourin Med; 1990 Dec; 66(6):418-22. PubMed ID: 2125023
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modeling the relationship between survival and CD4 lymphocytes in patients with AIDS and AIDS-related complex.
    De Gruttola V; Wulfsohn M; Fischl MA; Tsiatis A
    J Acquir Immune Defic Syndr (1988); 1993 Apr; 6(4):359-65. PubMed ID: 8095980
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Zidovudine--the first year of experience.
    Williams I; Gabriel G; Cohen H; Williams P; Tedder RS; Machin S; Weller IV
    J Infect; 1989 Jan; 18 Suppl 1():23-31. PubMed ID: 2915140
    [No Abstract]   [Full Text] [Related]  

  • 27. Didanosine therapy in patients intolerant of or failing zidovudine therapy.
    Rathbun RC; Martin ES
    Ann Pharmacother; 1992 Nov; 26(11):1347-51. PubMed ID: 1362093
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Natural history of advanced HIV disease in patients treated with zidovudine. The Zidovudine Epidemiology Study Group.
    Moore RD; Keruly J; Richman DD; Creagh-Kirk T; Chaisson RE
    AIDS; 1992 Jul; 6(7):671-7. PubMed ID: 1503686
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Zidovudine improves response to pneumococcal vaccine among persons with AIDS and AIDS-related complex.
    Glaser JB; Volpe S; Aguirre A; Simpkins H; Schiffman G
    J Infect Dis; 1991 Oct; 164(4):761-4. PubMed ID: 1894937
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of azidothymidine (AZT) on P24 antigen levels in patients with AIDS-related complex and AIDS.
    Reddy MM; McKinley G; Englard A; Grieco MH
    J Clin Lab Anal; 1989; 3(4):199-201. PubMed ID: 2503599
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases.
    Volberding PA; Lagakos SW; Koch MA; Pettinelli C; Myers MW; Booth DK; Balfour HH; Reichman RC; Bartlett JA; Hirsch MS
    N Engl J Med; 1990 Apr; 322(14):941-9. PubMed ID: 1969115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment of HIV infection with zidovudine. The good use of AZT].
    Régnier B
    Rev Prat; 1991 Sep; 41(19):1801-4. PubMed ID: 1925359
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of recombinant human granulocyte colony-stimulating factor on leucopenia in zidovudine-treated patients with AIDS and AIDS related complex, a phase I/II study.
    van der Wouw PA; van Leeuwen R; van Oers RH; Lange JM; Danner SA
    Br J Haematol; 1991 Jul; 78(3):319-24. PubMed ID: 1714756
    [TBL] [Abstract][Full Text] [Related]  

  • 34. National AIDS incidence trends and the extent of zidovudine therapy in selected demographic and transmission groups.
    Rosenberg PS; Gail MH; Schrager LK; Vermund SH; Creagh-Kirk T; Andrews EB; Winkelstein W; Marmor M; Des Jarlais DC; Biggar RJ
    J Acquir Immune Defic Syndr (1988); 1991; 4(4):392-401. PubMed ID: 2007974
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A pilot study of sequential therapy with zidovudine plus acyclovir, dideoxyinosine, and dideoxycytidine in patients with severe human immunodeficiency virus infection.
    Nguyen BY; Shay LE; Wyvill KM; Pluda JM; Brawley O; Cohen RB; Whitcup SM; Venzon DJ; Broder S; Yarchoan R
    J Infect Dis; 1993 Oct; 168(4):810-7. PubMed ID: 8397267
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Zidovudine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.
    Langtry HD; Campoli-Richards DM
    Drugs; 1989 Apr; 37(4):408-50. PubMed ID: 2661194
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alternating and intermittent regimens of zidovudine and dideoxycytidine in patients with AIDS or AIDS-related complex.
    Skowron G; Bozzette SA; Lim L; Pettinelli CB; Schaumburg HH; Arezzo J; Fischl MA; Powderly WG; Gocke DJ; Richman DD; Pottage JC; Antoniskis D; McKinley GF; Hyslop NE; Ray G; Simon G; Reed N; LoFaro ML; Uttamchandani RB; Gelb LD; Sperber SJ; Murphy RL; Leedom JM; Grieco MH; Zachary J; Hirsch MS; Spector SA; Bigley J; Soo W; Merigan TC
    Ann Intern Med; 1993 Mar; 118(5):321-30. PubMed ID: 8094279
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence on survival of p24 antigen levels in patients with AIDS or advanced AIDS related complex treated with zidovudine.
    Zamora L; Gatell JM; Barrera JM; Ercilla G; Gil C; Buira E; Miro JM; Soriano E
    Eur J Clin Microbiol Infect Dis; 1992 Dec; 11(12):1181-5. PubMed ID: 1291319
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical manifestations and predictors of disease progression in drug users with human immunodeficiency virus infection.
    Selwyn PA; Alcabes P; Hartel D; Buono D; Schoenbaum EE; Klein RS; Davenny K; Friedland GH
    N Engl J Med; 1992 Dec; 327(24):1697-703. PubMed ID: 1359411
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surrogate markers for survival in patients with AIDS and AIDS related complex treated with zidovudine.
    Jacobson MA; Bacchetti P; Kolokathis A; Chaisson RE; Szabo S; Polsky B; Valainis GT; Mildvan D; Abrams D; Wilber J
    BMJ; 1991 Jan; 302(6768):73-8. PubMed ID: 1671651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.